- We urge international locations to proceed utilizing this vital COVID-19 vaccine, says WHO chief.
- European, British regulators additionally say that advantages of AstraZeneca’s shot outweigh dangers.
- AstraZeneca vaccine is vital as a result of it accounts for greater than 90% of the vaccines being distributed by means of COVAX.
GENEVA: The World Well being Group (WHO) Friday referred to as on the world to maintain utilizing AstraZeneca’s coronavirus vaccine, including its endorsement to that of European and British regulators after considerations over blood clotting.
“We urge countries to continue using this important COVID-19 vaccine,” WHO Director Normal Tedros Adhanom Ghebreyesus instructed a information convention in Geneva.
He was talking after the worldwide well being physique’s vaccine security panel mentioned out there information concerning the AstraZeneca shot didn’t level to any general improve in clotting situations.
European and British regulators additionally mentioned this week that the advantages of AstraZeneca’s shot outweighed the dangers, prompting numerous nations to elevate their suspensions.
“The AstraZeneca vaccine is especially important because it accounts for more than 90% of the vaccines being distributed through COVAX,” Tedros added, referring to a WHO-led international vaccine-sharing scheme.
“There is no question. COVID-19 is a deadly disease, and the Oxford-AstraZeneca vaccine can prevent it. It’s also important to remember that COVID-19 itself can cause blood clots and low platelets.”
The WHO’s international advisory committee on vaccine security mentioned in a press release that the AstraZeneca vaccine had a “positive benefit-risk profile” and “tremendous potential” to stop infections and cut back deaths.
The WHO panel of 12 unbiased consultants, who met just about on Tuesday and on Thursday, reviewed security information from Europe, the UK, India, and WHO’s international database.
“While very rare and unique thromboembolic events in combination with thrombocytopenia, such as cerebral venous sinus thrombosis (CVST), have also been reported following vaccination with the AstraZeneca COVID-19 vaccine in Europe, it is not certain that they have been caused by vaccination,” it mentioned.